Intermittent Fasting vs Calorie Restriction: Which Works Better? Intermittent Fasting vs Calorie Restriction

People searching this question usually want to know whether fasting has some special effect beyond eating less. The year-long randomised trials give a fairly consistent answer: for weight and the usual heart and metabolic risk markers, intermittent fasting performs about the same as ordinary calorie restriction. The differences that do show up are in hunger, dropout and a small amount of lean mass.

This page compares the main fasting styles with daily restriction, then explains how to choose between them. For how eating windows work, see the time-restricted eating guide. This is general information, not medical advice.

The main approaches

• Daily calorie restriction: eating somewhat less every day, often around 25% below needs.
• Alternate-day fasting: very low intake on one day, normal or above-normal intake the next.
• The 5:2 diet: two low-calorie days a week and five ordinary days.
• Time-restricted eating: all food inside a daily window, such as 8 hours, often without counting calories.

All four aim to reduce total intake. The Cochrane review of fasting trials sorted them into four types (alternate-day, modified alternate-day, periodic and time-restricted) and compared each with eating freely or with continuous restriction. The question is whether the pattern adds anything beyond the deficit.

Year-long head-to-head trials

Alternate-day fasting vs daily restriction. In a 2017 trial in JAMA Internal Medicine, John Trepanowski and colleagues randomised 100 adults with obesity for a year. The fasting group ate 25% of energy needs on fast days and 125% on the days between; the restriction group ate 75% every day. Weight loss at 12 months was 6.0% with fasting and 5.3% with daily restriction, a difference that was not significant. Dropout was highest in the fasting group (38% vs 29%), and people tended to overeat on fast days and undereat on feast days. LDL cholesterol was higher in the fasting group by 11.5 mg/dL at month 12. The authors’ conclusion was that fasting “did not produce superior adherence, weight loss, weight maintenance, or cardioprotection”.

The 5:2 diet vs daily restriction. A 2018 Norwegian trial by Trine Sundfør and colleagues randomised 112 adults with abdominal obesity. The 5:2 group ate 400 or 600 kcal (women or men) on two non-consecutive days a week. Weight loss after six months was 8.0 kg with 5:2 and 9.0 kg with daily restriction, with similar small regain over the next six months. Hunger scores were higher on 5:2 (4.7 vs 3.6 on a rating scale), and the authors noted “feelings of hunger may be more pronounced during intermittent energy restriction”.

The German HELENA trial by Ruth Schübel and colleagues ran a similar comparison in 150 adults over 50 weeks. Both groups aimed for a weekly deficit of about 20%. After the 12-week diet phase, weight had fallen 7.1% with 5:2 and 5.2% with daily restriction. By week 50 the figures were 5.2% and 4.9%, and the authors judged 5:2 equivalent but not superior.

Time-restricted eating vs daily restriction. In the 2022 NEJM trial by Deying Liu and colleagues, 139 adults with obesity all followed the same calorie target (1,500 to 1,800 kcal a day for men, 1,200 to 1,500 for women). Half also ate only between 8 a.m. and 4 p.m. After 12 months the window group had lost 8.0 kg and the restriction-only group 6.3 kg, a difference that was not significant.

A 2023 trial in Annals of Internal Medicine by Shuhao Lin and colleagues compared an 8-hour window without calorie counting against a 25% daily restriction in 90 adults. Both groups cut intake by about 400 kcal a day (425 kcal with the window, 405 kcal with restriction). Weight loss compared with controls was 4.61 kg and 5.42 kg, with no significant difference between the two diets.

What the meta-analyses add

The Cochrane review by Allaf and colleagues found an average difference of only 0.88 kg compared with continuous restriction in the short term, with very low certainty, and little or no difference over 3 to 12 months.

A 2024 meta-analysis in Advances in Nutrition by Elortegui Pascual and colleagues pooled 28 trials. Weight differed by 0.42 kg, which was not significant. Intermittent plans lost about 0.20 kg more fat-free mass and 0.91 cm more waist, and glucose, insulin, lipids and blood pressure did not differ.

The largest analysis, a 2025 network meta-analysis in Nutrition Reviews, covered 167 trials and 11,998 participants. It ranked severe daily restriction first for weight loss, and concluded that results “mainly depends on the extent of the energy restriction, regardless of the mealtime patterns”. It also found that weight loss on intermittent plans tended to rebound after 12 weeks in subgroup analysis.

Blood pressure, lipids and glucose

Weight is not the only outcome. In the alternate-day fasting trial, there were no significant differences between the diets in blood pressure, triglycerides, fasting glucose, fasting insulin or C-reactive protein at 6 or 12 months. In the 5:2 trial, waist size, blood pressure, triglycerides and HDL cholesterol improved in both groups, again without a difference between them. The meta-analyses above reached the same conclusion for glucose, insulin, lipids and blood pressure. In other words, the metabolic gains seen with fasting look like the gains of losing weight by any route.

Where they differ

• Hunger. Very low-intake days can be hard. In the trials above, intermittent plans were rated hungrier or had more dropouts.
• Lean mass. The pooled data show a small extra loss of fat-free mass with intermittent plans. Adequate protein and resistance training help limit it; see intermittent fasting and muscle loss.
• LDL cholesterol. One year of alternate-day fasting raised LDL compared with daily restriction in one trial. Check your lipids if you try it, using the metabolic biomarkers guide.
• Simplicity. A fixed window needs no calorie tracking, which some people find easier. The Lin trial showed a window alone can produce a deficit similar to prescribed restriction.

Neither approach has been shown to extend human lifespan. For the animal and long-term evidence, see does intermittent fasting help you live longer.

How to choose

1. Pick the pattern you can keep for a year. In these trials, adherence mattered more than the method.
2. If you dislike counting, try a daily window of 8 to 10 hours, as in the Lin trial, and see whether intake falls on its own.
3. If very hungry days derail you, skip alternate-day fasting and 5:2. Daily restriction or a window may suit you better.
4. Keep protein and training steady to protect muscle.
5. Know what counts as fasting inside a window; see what breaks a fast.
6. Talk to a clinician first if you take insulin or other glucose-lowering drugs, are pregnant, or have a history of disordered eating.

This page is general information, not medical advice.